+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Insulin Market by Product Type, Insulin Type, Delivery Mode, End User, Distribution Channel - Global Forecast to 2030- Product Image
Insulin Market by Product Type, Insulin Type, Delivery Mode, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Insulin Market by Product Type, Insulin Type, Delivery Mode, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337609
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The insulin market stands at a pivotal juncture, shaped by rapid advances in therapy delivery, evolving regulatory requirements, and strategic investments to ensure supply chain resilience. As diabetes incidence rises worldwide, senior decision-makers face both critical challenges and opportunities to transform care, control costs, and drive sustainable business growth.

Market Snapshot: Insulin Market Growth Trajectory

The Insulin Market grew from USD 46.76 billion in 2024 to USD 50.44 billion in 2025. It is expected to continue growing at a CAGR of 7.72%, reaching USD 73.08 billion by 2030. This trajectory reflects robust global demand, supported by innovation in both drug formulations and delivery technologies. Expansion in both established and emerging regions is reinforced by ongoing regulatory adaptations, market-specific treatment paradigms, and increasing market access initiatives driven by payers and policymakers.

Scope & Segmentation

This report delivers a detailed analysis designed to inform strategic decisions in a dynamic marketplace. The research covers multiple perspectives across product types, insulin formulations, end users, delivery technologies, and distribution models, along with an in-depth breakdown by key geographies and leading competitors.

  • Product Types: Analog insulin, human insulin
  • Insulin Types: Intermediate acting, long acting, rapid acting, short acting, ultra long acting
  • Delivery Modes: Pen injectors, pumps, syringes
  • End Users: Clinics, home care settings, hospitals
  • Distribution Channels: Hospital pharmacies, online pharmacies, retail pharmacies
  • Regional Coverage: Americas (covering United States—including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (encompassing China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Company Coverage: Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Biocon Limited, Wockhardt Limited, Zhejiang Huahai Pharmaceutical Co., Ltd., Dong-A ST Co., Ltd., Bioton S.A., JW Pharmaceutical Corporation, and Fuji Pharma Co., Ltd.

Key Takeaways for Senior Decision-Makers

  • Innovation in ultra long-acting and rapid-acting insulin analogs is enabling tailored therapy regimens and shifting payer-provider dynamics.
  • Digital delivery ecosystems—such as connected pens and pump systems—are strengthening patient engagement and supporting remote care management.
  • Biosimilar entrants are intensifying competitive pressures, prompting manufacturers to diversify portfolios and realign pricing strategies.
  • Local and regional manufacturing investments are advancing supply reliability and helping mitigate future market disruptions.
  • Distribution channel evolution, notably through online pharmacies, is reshaping how patients access insulin, particularly in tech-oriented and developing regions.
  • Cross-sector collaborations are accelerating technology transfer, regulatory harmonization, and streamlined market access.

Tariff Impact: Strategic Response to U.S. Revisions

The 2025 U.S. tariff revisions have added cost pressures for both foreign suppliers and domestic manufacturers, affecting sourcing strategies and contract negotiations. These measures are prompting greater investment in onshore active pharmaceutical ingredient production and formulation facilities, increasing the complexity of procurement and reimbursement decisions. Stakeholders prioritizing agile contracting and supply diversification are better positioned to maintain patient access and operational margins in this environment.

Methodology & Data Sources

This analysis is founded on primary research via executive, clinical, and payer interviews, paired with a thorough review of regulatory filings, clinical trial data, and trade records. Consistency was ensured by data triangulation and expert panel review for validation, supporting the reliability of all observed trends and benchmarks.

Why This Report Matters

  • Delivers a holistic view, combining clinical, technological, and regulatory perspectives to inform executive-level strategy.
  • Enables leaders to anticipate sector disruptions by highlighting how market forces interact across geographies and customer segments.
  • Supports evidence-based investment in R&D, supply chain optimization, and new product development for sustainable business outcomes.

Conclusion

The insulin market is marked by strategic realignment, technological advancement, and a growing emphasis on supply chain resilience. Senior leaders equipped with these insights can confidently steer their organizations in pursuit of long-term value and operational excellence.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Insulin Market, by Product Type
8.1. Introduction
8.2. Analog Insulin
8.3. Human Insulin
9. Insulin Market, by Insulin Type
9.1. Introduction
9.2. Intermediate Acting
9.3. Long Acting
9.4. Rapid Acting
9.5. Short Acting
9.6. Ultra Long Acting
10. Insulin Market, by Delivery Mode
10.1. Introduction
10.2. Pen Injectors
10.3. Pumps
10.4. Syringes
11. Insulin Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Care
11.4. Hospitals
12. Insulin Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacies
12.3. Online Pharmacies
12.4. Retail Pharmacies
13. Americas Insulin Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Insulin Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Insulin Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Novo Nordisk a/S
16.3.2. Eli Lilly and Company
16.3.3. Sanofi S.A.
16.3.4. Biocon Limited
16.3.5. Wockhardt Limited
16.3.6. Zhejiang Huahai Pharmaceutical Co., Ltd.
16.3.7. Dong-A ST Co., Ltd.
16.3.8. Bioton S.A.
16.3.9. JW Pharmaceutical Corporation
16.3.10. Fuji Pharma Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. INSULIN MARKET MULTI-CURRENCY
FIGURE 2. INSULIN MARKET MULTI-LANGUAGE
FIGURE 3. INSULIN MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL INSULIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL INSULIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL INSULIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INSULIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INSULIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INSULIN MARKET SIZE, BY INSULIN TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INSULIN MARKET SIZE, BY INSULIN TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INSULIN MARKET SIZE, BY DELIVERY MODE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INSULIN MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INSULIN MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL INSULIN MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS INSULIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS INSULIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES INSULIN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES INSULIN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC INSULIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC INSULIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. INSULIN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. INSULIN MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. INSULIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INSULIN MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL INSULIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL INSULIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL INSULIN MARKET SIZE, BY ANALOG INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL INSULIN MARKET SIZE, BY HUMAN INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL INSULIN MARKET SIZE, BY INTERMEDIATE ACTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL INSULIN MARKET SIZE, BY LONG ACTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL INSULIN MARKET SIZE, BY RAPID ACTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL INSULIN MARKET SIZE, BY SHORT ACTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL INSULIN MARKET SIZE, BY ULTRA LONG ACTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL INSULIN MARKET SIZE, BY PEN INJECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL INSULIN MARKET SIZE, BY PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL INSULIN MARKET SIZE, BY SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL INSULIN MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL INSULIN MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL INSULIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL INSULIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL INSULIN MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL INSULIN MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS INSULIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES INSULIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. CANADA INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 40. CANADA INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 41. CANADA INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 42. CANADA INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. CANADA INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. MEXICO INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 45. MEXICO INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 47. MEXICO INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. MEXICO INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. UNITED KINGDOM INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. UNITED KINGDOM INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 67. UNITED KINGDOM INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 68. UNITED KINGDOM INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. UNITED KINGDOM INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. GERMANY INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. GERMANY INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 72. GERMANY INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 73. GERMANY INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. GERMANY INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. FRANCE INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. FRANCE INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 77. FRANCE INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 78. FRANCE INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. FRANCE INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. RUSSIA INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. ITALY INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. ITALY INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 87. ITALY INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 88. ITALY INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. ITALY INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. SPAIN INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. SPAIN INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 92. SPAIN INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 93. SPAIN INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. SPAIN INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 98. UNITED ARAB EMIRATES INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. UNITED ARAB EMIRATES INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. SAUDI ARABIA INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. SAUDI ARABIA INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 102. SAUDI ARABIA INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 103. SAUDI ARABIA INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. SAUDI ARABIA INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. SOUTH AFRICA INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. SOUTH AFRICA INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 107. SOUTH AFRICA INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 108. SOUTH AFRICA INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. SOUTH AFRICA INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. DENMARK INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. DENMARK INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 112. DENMARK INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 113. DENMARK INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. DENMARK INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. NETHERLANDS INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. NETHERLANDS INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 117. NETHERLANDS INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 118. NETHERLANDS INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. NETHERLANDS INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. QATAR INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 121. QATAR INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 122. QATAR INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 123. QATAR INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. QATAR INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. FINLAND INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. FINLAND INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 127. FINLAND INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 128. FINLAND INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. FINLAND INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. EGYPT INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. EGYPT INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 142. EGYPT INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 143. EGYPT INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. EGYPT INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. TURKEY INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. TURKEY INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 147. TURKEY INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 148. TURKEY INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. TURKEY INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. ISRAEL INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. ISRAEL INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. NORWAY INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. NORWAY INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 157. NORWAY INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 158. NORWAY INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. NORWAY INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. POLAND INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. POLAND INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 162. POLAND INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 163. POLAND INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. POLAND INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. SWITZERLAND INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. SWITZERLAND INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 167. SWITZERLAND INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 168. SWITZERLAND INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. SWITZERLAND INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC INSULIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 176. CHINA INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. CHINA INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 178. CHINA INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 179. CHINA INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. CHINA INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. INDIA INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. INDIA INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 183. INDIA INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 184. INDIA INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. INDIA INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. JAPAN INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. JAPAN INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 188. JAPAN INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 189. JAPAN INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. JAPAN INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 194. AUSTRALIA INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. AUSTRALIA INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 204. INDONESIA INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. INDONESIA INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. THAILAND INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. THAILAND INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 208. THAILAND INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 209. THAILAND INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. THAILAND INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. PHILIPPINES INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. PHILIPPINES INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 213. PHILIPPINES INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 214. PHILIPPINES INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. PHILIPPINES INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. MALAYSIA INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 221. SINGAPORE INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 222. SINGAPORE INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 223. SINGAPORE INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 224. SINGAPORE INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. SINGAPORE INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN INSULIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN INSULIN MARKET SIZE, BY INSULIN TYPE, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN INSULIN MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 234. TAIWAN INSULIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. TAIWAN INSULIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. INSULIN MARKET SHARE, BY KEY PLAYER, 2024
TABLE 237. INSULIN MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Insulin market report include:
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Sanofi S.A.
  • Biocon Limited
  • Wockhardt Limited
  • Zhejiang Huahai Pharmaceutical Co., Ltd.
  • Dong-A ST Co., Ltd.
  • Bioton S.A.
  • JW Pharmaceutical Corporation
  • Fuji Pharma Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 50.44 Billion
Forecasted Market Value ( USD ) by 2030 $ 73.08 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Insulin Delivery Devices Market by Delivery Method, Insulin Type, Distribution Channel, End User - Global Forecast to 2030 - Product Image

Insulin Delivery Devices Market by Delivery Method, Insulin Type, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Continuous Subcutaneous Insulin Infusion Market by Product Type, Insulin Type, Distribution Channel, End User, Age Group - Global Forecast to 2030 - Product Image

Continuous Subcutaneous Insulin Infusion Market by Product Type, Insulin Type, Distribution Channel, End User, Age Group - Global Forecast to 2030

  • Report
  • 187 Pages
  • Global
From
Insulin Market Size, Share & Trends Analysis Report By Product, By Application, By Type, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Insulin Market Size, Share & Trends Analysis Report By Product, By Application, By Type, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Insulin Delivery Devices Market Size, Share & Trends Analysis Report By Product (Reusable Insulin Pens, Disposable Insulin Pens), By End Use (Hospitals & Clinics, Homecare), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Insulin Delivery Devices Market Size, Share & Trends Analysis Report By Product (Reusable Insulin Pens, Disposable Insulin Pens), By End Use (Hospitals & Clinics, Homecare), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
Short-Acting Insulin - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Short-Acting Insulin - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From

About the Insulin Market

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump. The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.
OSZAR »